MARSHALL WACE, LLP - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 103 filers reported holding CYTOSORBENTS CORP in Q2 2021. The put-call ratio across all filers is 2.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2021$31,000
-76.5%
7,627
-56.3%
0.00%
-100.0%
Q2 2021$132,000
+300.0%
17,458
+333.7%
0.00%
Q4 2018$33,0004,0250.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders